Infectious agents and gene-environmental interactions in the etiopathogenesis of schizophrenia

Clinical Neuroscience Research

Volumn 6, Issue 1-2, 2006, Pages 97-109

  Yolken, Robert H ^a   Torrey, E Fuller ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Stanley Medical Research Institute   (United States)

Author keywords

Etiopathogenesis; Schizophrenia; Toxoplasma gondii

Indexed keywords

ARTEMISININ; ARTEMISININ DERIVATIVE; SULFONAMIDE; TRIMETHOPRIM; VALPROIC ACID;

APICOMPLEXA; ARTICLE; BORNA DISEASE VIRUS; BORRELIA BURGDORFERI; CHLAMYDIA; CLINICAL TRIAL; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENTEROVIRUS; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS A; MEDICAL RESEARCH; NONHUMAN; POLIOMYELITIS VIRUS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RETROVIRUS; RUBELLA VIRUS; SCHIZOPHRENIA; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT PLANNING;

EID: 33746714935     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnr.2006.05.003     Document Type: Article

References (124)

1. Collier D.A., and Li T. The genetics of schizophrenia: glutamate not dopamine?. Eur J Pharmacol 480 1-3 (2003) 177-184
2. Hennah W., Varilo T., Paunio T., and Peltonen L. Haplotype analysis and identification of genes for a complex trait: examples from schizophrenia. Ann Med 36 5 (2004) 322-331
3. Kohn Y., and Lerer B. Genetics of schizophrenia: a review of linkage findings. Isr J Psychiatry Relat Sci 39 4 (2002) 340-351
4. Levinson D.F. Meta-analysis in Psychiatric Genetics. Curr Psychiatry Rep 7 2 (2005) 143-151
5. Kendler K.S. Schizophrenia genetics and dysbindin: a corner turned?. Am J Psychiatry 161 9 (2004) 1533-1536
6. Northup A., and Nimgaonkar V.L. Genetics of schizophrenia: implications for treatment. Expert Rev Neurother 4 4 (2004) 725-731
7. Torrey E.F., Miller J., Rawlings R., and Yolken R.H. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res 28 1 (1997) 1-38
8. Mortensen P.B., Pedersen C.B., Westergaard T., et al. Effects of family history and place and season of birth on the risk of schizophrenia. N Engl J Med 340 8 (1999) 603-668
9. Agerbo E., Torrey E.F., and Mortensen P.B. Household crowding in early adulthood and schizophrenia are unrelated in Denmark: a nested case-control study. Schizophr Res 47 2-3 (2001) 243-266
10. Cantor-Graae E., and Selten J.P. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 162 1 (2005) 12-24
11. St Clair D., Xu M., Wang P., et al. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. J Am Med Assoc 294 5 (2005) 557-562
12. Geddes J.R., Verdoux H., Takei N., et al. Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis. Schizophr Bull 25 3 (1999) 413-423
13. Fuller Torrey E., Rawlings R., and Yolken R.H. The antecedents of psychoses: a case-control study of selected risk factors. Schizophr Res 46 1 (2000) 17-23
14. Petronis A. The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis. Biol Psychiatry 55 10 (2004) 965-970
15. Woolf C.M. Does the genotype for schizophrenia often remain unexpressed because of canalization and stochastic events during development?. Psychol Med 27 3 (1997) 659-668
16. Kremen W.S., Buka S.L., and Seidman L.J. IQ decline during childhood and adult psychotic symptoms in a community sample: a 19-year longitudinal study. Am J Psychiatry 155 5 (1998) 672-677
17. Meyer U., Feldon J., Schedlowski M., and Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 29 6 (2005) 913-947
18. Brown A.S., and Susser E.S. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev 8 1 (2002) 51-57
19. Brown A.S., Schaefer C.A., Quesenberry Jr. C.P., Liu L., Babulas V.P., and Susser E.S. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 162 4 (2005) 767-773
20. Mortensen P.B., Yolken R.H., Lindum B., Sorensen T., Hougaard D., and Pederson B. Toxoplamosis and other early infections in relation to schizophrenia risk. Schizophr Bull 31 (2005) 232
21. Brown A.S., Begg M.D., Gravenstein S., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61 8 (2004) 774-780
22. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Bernstein D., and Yolken R.H. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 58 11 (2001) 1032-1077
23. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Wagner R.L., and Yolken R.H. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 15 4 (2001) 411-420
24. Koponen H., Rantakallio P., Veijola J., Jones P., Jokelainen J., and Isohanni M. Childhood central nervous system infections and risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 254 1 (2004) 9-13
25. Herrmann K.L. Rubella in the United States: toward a strategy for disease control and elimination. Epidemiol Infect 107 1 (1991) 55-61
26. Torrey E.F., and Yolken R.H. Toxoplasma gondii and schizophrenia. Emerg Infect Dis 9 11 (2003) 1375-1380
27. Leweke F.M., Gerth C.W., Koethe D., et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 254 1 (2004) 4-8
28. Dickerson F.B., Boronow J.J., Stallings C.R., Origoni A.E., and Yolken R.H. Reduction of symptoms by valacyclovir in cytomegalovirus-seropositive individuals with schizophrenia. Am J Psychiatry 160 12 (2003) 2234-2266
29. Prasad K, Shirt, B., Yolken, R., Keshavan, M., Nimagaonkar, V. HSV-1 infections and brain morphological changes in first episode schizophrenia. submitted for publication.
30. Dickerson F.B., Boronow J.J., Stallings C., et al. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry 55 6 (2004) 588-593
31. Torrey E.F. Functional psychosis and viral encephalitis. Integr Psychiatry 4 (1986) 224-4236
32. Caroff S., Mann S., Gliatto M., Sullivan K., and Campbell C. Psychiatric manifestations of acute viral encephalitis. Psychiatric Annuals 31 (2001) 193-204
33. Schwemmle M., and Billich C. The use of peptide arrays for the characterization of monospecific antibody repertoires from polyclonal sera of psychiatric patients suspected of infection by Borna Disease Virus. Mol Divers 8 3 (2004) 247-250
34. Hinze-Selch D., and Pollmacher T. In vitro cytokine secretion in individuals with schizophrenia: results, confounding factors, and implications for further research. Brain Behav Immun 15 4 (2001) 282-318
35. Bar K.J., Jochum T., Hager F., Meissner W., and Sauer H. Painful hallucinations and somatic delusions in a patient with the possible diagnosis of neuroborreliosis. Clin J Pain 21 4 (2005) 362-363
36. Hess A., Buchmann J., Zettl U.K., et al. Borrelia burgdorferi central nervous system infection presenting as an organic schizophrenialike disorder. Biol Psychiatry 45 6 (1999) 795
37. Dolder C.R., Patterson T.L., and Jeste D.V. HIV, psychosis and aging: past, present and future. Aids 18 Suppl. 42 (2004) S35-S42
38. Mahajan S.K., Machhan P.C., Sood B.R., et al. Neurocysticercosis presenting with psychosis. J Assoc Physicians India 52 (2004) 663-665
39. Kochar D.K., Shubhakaran, Kumawat B.L., et al. Cerebral malaria in Indian adults: a prospective study of 441 patients from Bikaner, north-west India. J Assoc Physicians India 50 (2002) 234-241
40. Kohler C.G., Pickholtz J., and Ballas C. Neurosyphilis presenting as schizophrenialike psychosis. Neuropsychiatry Neuropsychol Behav Neurol 13 4 (2000) 297-302
41. Chien Y.H., Lee P.I., Huang L.M., Lee C.Y., Lin D.T., and Lin K.H. Typhoid fever presenting as infection-associated hemophagocytic syndrome: report of one case. Acta Paediatr Taiwan 40 5 (1999) 339-340
42. Spieker S., Petersen D., Rolfs A., et al. Acute disseminated encephalomyelitis following Pontiac fever. Eur Neurol 40 3 (1998) 169-172
43. Nahmias A.J., Lee F.K., and Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 69 (1990) 19-36
44. Smith J.S., and Robinson N.J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 186 Suppl. 1 (2002) S3-S28
45. Zolopa A.R., Hahn J.A., Gorter R., et al. HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. J Am Med Assoc 272 6 (1994) 455-461
46. Hinze-Selch D., Becker E.W., Stein G.M., et al. Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients. Neuropsychopharmacology 19 2 (1998) 114-122
47. Conejero-Goldberg C., Torrey E.F., and Yolken R.H. Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr Res 60 1 (2003) 65-69
48. Taller A.M., Asher D.M., Pomeroy K.L., et al. Search for viral nucleic acid sequences in brain tissues of patients with schizophrenia using nested polymerase chain reaction. Arch Gen Psychiatry 53 1 (1996) 32-40
49. McDonald C., and Murphy K.C. The new genetics of schizophrenia. Psychiatr Clin North Am 26 1 (2003) 41-63
50. Singh N., Agrawal S., and Rastogi A.K. Infectious diseases and immunity: special reference to major histocompatibility complex. Emerg Infect Dis 3 1 (1997) 41-49
51. Lane P.A., O'Connell J.L., Lear J.L., et al. Functional asplenia in hemoglobin SC disease. Blood 85 8 (1995) 2238-2244
52. Canonne-Hergaux F., Gruenheid S., Govoni G., and Gros P. The Nramp1 protein and its role in resistance to infection and macrophage function. Proc Assoc Am Physicians 111 4 (1999) 283-299
53. Koh W.J., Kwon O.J., Kim E.J., Lee K.S., Ki C.S., and Kim J.W. NRAMP1 gene polymorphism and susceptibility to nontuberculous mycobacterial lung diseases. Chest 128 1 (2005) 94-101
54. Rad R., Prinz C., Neu B., et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 188 2 (2003) 272-281
55. Hamajima N. Persistent Helicobacter pylori infection and genetic polymorphisms of the host. Nagoya J Med Sci 66 3-4 (2003) 103-117
56. Thye T., Burchard G.D., Nilius M., Muller-Myhsok B., and Horstmann R.D. Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection. Am J Hum Genet 72 2 (2003) 448-453
57. Kunstmann E., Hardt C., Elitok E., et al. The nonfunctional allele TCRBV6S1B is strongly associated with Helicobacter pylori infection. Infect Immun 68 11 (2000) 6493-6495
58. Gyulai Z., Klausz G., Tiszai A., et al. Genetic polymorphism of interleukin-8 (IL-8) is associated with Helicobacter pylori-induced duodenal ulcer. Eur Cytokine Netw 15 4 (2004) 353-358
59. Glas J., Torok H.P., Schneider A., et al. Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. J Clin Oncol 22 23 (2004) 4746-4752
60. Ottenhoff T.H., De Boer T., van Dissel J.T., and Verreck F.A. Human deficiencies in type-1 cytokine receptors reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Adv Exp Med Biol 531 (2003) 279-294
61. Zanardini R., Bocchio-Chiavetto L., Scassellati C., et al. Association between IL-1beta -511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia. J Psychiatr Res 37 6 (2003) 457-462
62. Schwarz M.J., Kronig H., Riedel M., et al. IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur Arch Psychiatry Clin (2005)
63. Yu L., Yang M.S., Zhao J., et al. An association between polymorphisms of the interleukin-10 gene promoter and schizophrenia in the Chinese population. Schizophr Res 71 1 (2004) 179-183
64. Saviouk V., Chow E.W., Bassett A.S., and Brzustowicz L.M. Tumor necrosis factor promoter haplotype associated with schizophrenia reveals a linked locus on 1q44. Mol Psychiatry 10 4 (2005) 375-383
65. Jun T.Y., Pae C.U., Chae J.H., et al. TNFB polymorphism may be associated with schizophrenia in the Korean population. Schizophr Res 61 1 (2003) 39-45
66. Kronig H., Riedel M., Schwarz M.J., et al. ICAM G241A polymorphism and soluble ICAM-1 serum levels: evidence for an active immune process in schizophrenia. Neuroimmunomodulation 12 1 (2005) 54-59
67. Wright P., Donaldson P.T., Underhill J.A., Choudhuri K., Doherty D.G., and Murray R.M. Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia. Am J Psychiatry 153 12 (1996) 1530-1533
68. Jun T.Y., Pae C.U., Chae J.H., Bahk W.M., Kim K.S., and Han H. Polymorphism of CTLA-4 gene at position 49 of exon 1 may be associated with schizophrenia in the Korean population. Psychiatry Res 110 1 (2002) 19-25
69. Jones A.L., Mowry B.J., Pender M.P., and Greer J.M. Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?. Immunol Cell Biol 83 1 (2005) 9-17
70. Duan S., Xu Y., Chen W., et al. No association between the promoter variants of tumor necrosis factor alpha (TNF-alpha) and schizophrenia in Chinese Han population. Neurosci Lett 366 2 (2004) 139-143
71. Singh K.K., Barroga C.F., Hughes M.D., et al. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection. J Infect Dis 188 10 (2003) 1461-1472
72. Puissant B., Abbal M., and Blancher A. Polymorphism of human and primate RANTES, CX3CR1, CCR2 and CXCR4 genes with regard to HIV/SIV infection. Immunogenetics 55 5 (2003) 275-283
73. Goulding C., Murphy A., MacDonald G., et al. The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source. Gut 54 8 (2005) 1157-1161
74. Ryan F.P. Human endogenous retroviruses in health and disease: a symbiotic perspective. J R Soc Med 97 12 (2004) 560-565
75. Muir A., Lever A., and Moffett A. Expression and functions of human endogenous retroviruses in the placenta: an update. Placenta 25 Suppl. A (2004) S16-S25
76. Prudhomme S., Oriol G., and Mallet F. A retroviral promoter and a cellular enhancer define a bipartite element which controls env ERVWE1 placental expression. J Virol 78 22 (2004) 12157-12168
77. Hatada S., Grant D.J., and Maeda N. An intronic endogenous retrovirus-like sequence attenuates human haptoglobin-related gene expression in an orientation-dependent manner. Gene 319 (2003) 55-63
78. Lee W.J., Kwun H.J., Kim H.S., and Jang K.L. Activation of the human endogenous retrovirus W long terminal repeat by herpes simplex virus type 1 immediate early protein 1. Mol Cells 15 1 (2003) 75-80
79. Sutkowski N., Chen G., Calderon G., and Huber B.T. Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen. J Virol 78 14 (2004) 7852-7860
80. Gazzinelli R.T., Sher A., Cheever A., Gerstberger S., Martin M.A., and Dickie P. Infection of human immunodeficiency virus 1 transgenic mice with Toxoplasma gondii stimulates proviral transcription in macrophages in vivo. J Exp Med 183 4 (1996) 1645-1655
81. Macfarlane C., and Simmonds P. Allelic variation of HERV-K(HML-2) endogenous retroviral elements in human populations. J Mol Evol 59 5 (2004) 642-656
82. Marguerat S., Wang W.Y., Todd J.A., and Conrad B. Association of human endogenous retrovirus K-18 polymorphisms with type 1 diabetes. Diabetes 53 3 (2004) 852-884
83. Clausen J. Endogenous retroviruses and MS: using ERVs as disease markers. Int MS J 10 1 (2003) 22-28
84. Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol 15 3 (2005) 179-211
85. Karlsson H., Bachmann S., Schroder J., et al. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Natl Acad Sci USA 98 8 (2001) 4634-4639
86. Karlsson H., Schroder J., Bachmann S., Bottmer C., and Yolken R.H. HERV-W-related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder. Mol Psychiatry 9 1 (2004) 12-13
87. Frank O., Giehl M., Zheng C., Hehlmann R., Leib-Mosch C., and Seifarth W. Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders. J Virol 79 17 (2005) 10890-10901
88. Hill A.R. The environment and disease: association or causation?. Proc Royal Soc Med 58 (1965) 295-300
89. Evans A.S. Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med 49 2 (1976) 175-195
90. Niebuhr D.N., Yolken R.H., Millikan A.M., Cowan D., and Li Y. The Military New Onset Psychosis Project-A resource for the study of gene environmental interactions among persons with severe mental illness. Schizophr Bull 31 (2005) 233
91. Brewer W.J., Francey S.M., Wood S.J., et al. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry 162 1 (2005) 71-78
92. Stibbs H.H. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol 79 2 (1985) 153-157
93. Silva N.M., Rodrigues C.V., Santoro M.M., Reis L.F., Alvarez-Leite J.I., and Gazzinelli R.T. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1. Infect Immun 70 2 (2002) 859-868
94. Miller C.L., Llenos I.C., Dulay J.R., Barillo M.M., Yolken R.H., and Weis S. Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol Dis 15 3 (2004) 618-629
95. Rozenfeld C., Martinez R., Figueiredo R.T., et al. Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration. Infect Immun 71 4 (2003) 2047-2057
96. Webster J.P. Rats, cats, people and parasites: the impact of latent toxoplasmosis on behaviour. Microbes Infect 3 12 (2001) 1037-1045
97. Novotna M., Hanusova J., Klose J., et al. Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host. BMC Infect Dis 5 (2005) 54
98. Zhang X.Y., Zhou D.F., Zhang P.Y., Wu G.Y., Cao L.Y., and Shen Y.C. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophr Res 57 2-3 (2002) 247-258
99. Wang C., McInnis J., Ross-Sanchez M., Shinnick-Gallagher P., Wiley J.L., and Johnson K.M. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience 107 4 (2001) 535-550
100. Sun Y., Zhang L., Johnston N.L., Torrey E.F., and Yolken R.H. Serial analysis of gene expression in the frontal cortex of patients with bipolar disorder. Br J Psychiatry Suppl 41 (2001) s137-s141
101. Macpherson C.N. Human behaviour and the epidemiology of parasitic zoonoses. Int J (2005)
102. Jones-Brando L., Torrey E.F., and Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 62 3 (2003) 237-244
103. Citrome L. Schizophrenia and valproate. Psychopharmacol Bull 37 Suppl. 2 (2003) 74-88
104. Vigneswaran R. Infection and preterm birth: evidence of a common causal relationship with bronchopulmonary dysplasia and cerebral palsy. J Paediatr Child Health 36 4 (2000) 293-296
105. Shaw M.H., Boyartchuk V., Wong S., et al. A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity. Proc Natl Acad Sci USA 100 20 (2003) 11594-11599
106. Mason N.J., Artis D., and Hunter C.A. New lessons from old pathogens: what parasitic infections have taught us about the role of nuclear factor-kappaB in the regulation of immunity. Immunol Rev 201 (2004) 48-56
107. Suzue K., Asai T., Takeuchi T., and Koyasu S. In vivo role of IFN-gamma produced by antigen-presenting cells in early host defense against intracellular pathogens. Eur J Immunol 33 10 (2003) 2666-2675
108. Yap G.S., Ortmann R., Shevach E., and Sher A. A heritable defect in IL-12 signaling in B10.Q/J mice. II. Effect on acute resistance to Toxoplasma gondii and rescue by IL-18 treatment. J Immunol 166 9 (2001) 5720-5725
109. Del Rio L., Bennouna S., Salinas J., and Denkers E.Y. CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. J Immunol 167 11 (2001) 6503-6509
110. Nuesch R., Geigy N., Schaedler E., and Battegay M. Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients. Eur J Clin Microbiol Infect Dis 21 9 (2002) 684-687
111. Capizzi S.A., and Specks U. Does infection play a role in the pathogenesis of pulmonary vasculitis?. Semin Respir Infect 18 1 (2003) 17-22
112. Itzhaki R.F., Dobson C.B., Shipley S.J., and Wozniak M.A. The role of viruses and of APOE in dementia. Ann NY Acad Sci 1019 (2004) 15-18
113. Moses Jr. H., and Sriram S. An infectious basis for multiple sclerosis: perspectives on the role of Chlamydia pneumoniae and other agents. BioDrugs 15 3 (2001) 199-206
114. Georgiev V.S. Management of toxoplasmosis. Drugs 48 2 (1994) 179-188
115. van der Ven A.J., Schoondermark-van de Ven E.M., Camps W., et al. Anti-toxoplasma effect of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapy. J Antimicrob Chemother 38 1 (1996) 75-80
116. Vennerstrom J.L., Arbe-Barnes S., Brun R., et al. Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 430 7002 (2004) 900-904
117. Ke O.Y., Krug E.C., Marr J.J., and Berens R.L. Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives. Antimicrob Agents Chemother 34 10 (1990) 1961-1965
118. Citrome L., Goldberg J.F., and Stahl S.M. Toward convergence in the medication treatment of bipolar disorder and schizophrenia. Harv Rev Psychiatry 13 1 (2005) 28-42
119. Suvisaari J., Haukka J., Tanskanen A., Hovi T., and Lonnqvist J. Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am J Psychiatry 156 7 (1999) 1100-1102
120. Rantakallio P., Jones P., Moring J., and Von Wendt L. Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. Int J Epidemiol 26 4 (1997) 837-843
121. Terayama H., Nishino Y., Kishi M., Ikuta K., Itoh M., and Iwahashi K. Detection of anti-Borna Disease Virus (BDV) antibodies from patients with schizophrenia and mood disorders in Japan. Psychiatry Res 120 2 (2003) 201-206
122. Sewell D.D. Schizophrenia and HIV. Schizophr Bull 22 3 (1996) 465-473
123. Fallon B.A., and Nields J.A. Lyme disease: a neuropsychiatric illness. Am J Psychiatry 151 11 (1994) 1571-1583
124. Fellerhoff B., Laumbacher B., and Wank R. High risk of schizophrenia and other mental disorders associated with chlamydial infections: hypothesis to combine drug treatment and adoptive immunotherapy. Med Hypotheses 65 2 (2005) 243-252